No Detail Found!

Assessing the value of early detection of coagulopathies in corona virus disease 19 patients in Dow University of Health Sciences Karachi, Pakistan

Author(s)
Shaheen Kouser Departments of Pathology, Dr. Ishrat-ul-Ebad Khan Institute of Blood Diseases (DIEKIBD), Dow University of Health Science, Karachi, Pakistan
Saba Kamil Departments of Pathology, Dr. Ishrat-ul-Ebad Khan Institute of Blood Diseases (DIEKIBD), Dow University of Health Science, Karachi, Pakistan
Ramsha Khan Departments of Pathology, Dr. Ishrat-ul-Ebad Khan Institute of Blood Diseases (DIEKIBD), Dow University of Health Science, Karachi, Pakistan
Farah Fatima Abbass Departments of Pathology, Dr. Ishrat-ul-Ebad Khan Institute of Blood Diseases (DIEKIBD), Dow University of Health Science, Karachi, Pakistan
Nehad Khan Departments of Pathology, Dr. Ishrat-ul-Ebad Khan Institute of Blood Diseases (DIEKIBD), Dow University of Health Science, Karachi, Pakistan
Sara Rashid Departments of Pathology, Contonement Board Malir Health Center, Karachi, Pakistan
Abstract
Objective: To assess the coagulopathies at the time of diagnosis of Covid-19. Methodology: This cross sectional retrospective study included 8000 patients from March 2020 to March 2021, out of them only 347 patients were analyzed in this study due to insufficient data. Descriptive statistics were summarized as percentages, means, and standard deviations. Paired t test for comparison between day 1 and day 7 of the admission. Results: Out of 347 patients, 207 (59.6%) were male, and 140 (40.3%) females. The average age was 57 years; most (47%) belonged to senior age group. As opposed to other age groups, most of the elderly (61 to 90 years old) patients showed abnormal D dimer, PT, and INR. There was no difference in the admitted patient’s D dimer on Days 1 and 7 (p=0.36, 95% CI = -0.07622-0.02774). Conclusion: D-dimer and other coagulation markers were higher than normal at admission in adult COVID-19 patients. The assessment of these markers upon admission may be helpful in identifying risk and initiating testing for severe COVID-19 cases, leading to rapid COVID-19 therapy and the avoidance of mortality.
Publication Details
Page(s) 1-3
DOI DOI not available
Published Journal: Rawal Medical Journal, Volume: 49, Issue: 2, Year: 2024

Request the full text from PASTIC

Keywords
COVID 19, Prothrombin Time., INR, fibrin fragment D dimer
References
Levi M,Hunt BJ .2020 .Thrombosis and coagulopathy in COVID‐19: an illustrated review. Res pract Thromb Haemost, 4 : 744-51.
Abid K,Bari YA,Younas M,Javaid ST,Imran A .2020 .. Progress of COVID-19 Epidemic in Pakistan. Asia Pac J Public Health, 32 : 154-6.
Noreen N,Dil S,Niazi S,Naveed I,Khan NU,Khanet FK .2020 .Pakistan; limitations and gaps. Global Biosecurity, 1(3) : .
Naqvi IH,Alam MT,Rehan M,Mahmood K,Aurangzeb M,Talib A .2022 .-associated coagulopathy and thromboembolism: determination of their patterns and risk factors as predictors of mortality among severe COVID19 patients. Curr Vascul Pharmacol, 20 : 77-86.
Jin JM,Bai P,He W,Wu F,Liu XF,Han DM .2020 .Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Front Public Health, 8 : 152-7.
Raza HA,Sen P,Bhatti OA,Gupta L .2021 .Sex hormones, autoimmunity and gender disparity. in COVID-19. Rheum Int, 41 : 1375-86.
Takahashi T,Ellingson MK,Wong P,Israelow B,Lucas C,Klein J .2020 .Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature, 588 : 315-20.
Singhal S,Kumar P,Singh S,Saha S,Dey AB. .2021 .Clinical features and outcomes of COVID-19 in older adults: A systematic review and meta-analysis. BMC Geriatrics, 21 : 321-6.
Rostami M,Mansouritorghabeh H M .2020 .D-dimer level in COVID-19 infection: a systematic review. Exp Rev Hematol, 13 : 1265-75.
Kouhpayeh H. .2022 .Clinical features predicting COVID-19 mortality risk. Eur J Trans Myol, 32 : 10268.
Huang C,Wang Y,Li X,Ren L,Zhao J,Hu Y .2020 .Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395 : 497-506.
0

Citations

0

Downloads

43

Views